Teruhito Yoshitaka
Overview
Explore the profile of Teruhito Yoshitaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Srivastava T, Garola R, Zhou J, Boinpelly V, Rezaiekhaligh M, Joshi T, et al.
JCI Insight
. 2023 Dec;
9(3).
PMID: 38127456
Despite clinical use of immunosuppressive agents, the immunopathogenesis of minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) remains unclear. Src homology 3-binding protein 2 (SH3BP2), a scaffold protein, forms...
2.
Yoshitaka T, Shimaoka Y, Yamanaka I, Tanida A, Tanimoto J, Toda N, et al.
Prog Rehabil Med
. 2022 May;
7:20220026.
PMID: 35633759
Objectives: Hip fracture is a common injury occurring in elderly people and often impairs their activities of daily living (ADL). This study aimed to identify and analyze factors associated with...
3.
Kittaka M, Mayahara K, Mukai T, Yoshimoto T, Yoshitaka T, Gorski J, et al.
J Bone Miner Res
. 2017 Sep;
33(1):167-181.
PMID: 28914985
Currently, it is believed that osteoclasts positive for tartrate-resistant acid phosphatase (TRAP+) are the exclusive bone-resorbing cells responsible for focal bone destruction in inflammatory arthritis. Recently, a mouse model of...
4.
Mukai T, Gallant R, Ishida S, Kittaka M, Yoshitaka T, Fox D, et al.
Arthritis Rheumatol
. 2014 Dec;
67(3):656-67.
PMID: 25470448
Objective: SH3 domain-binding protein 2 (SH3BP2) is a signaling adapter protein that regulates the immune and skeletal systems. The present study was undertaken to investigate the role of SH3BP2 in...
5.
Yoshitaka T, Kittaka M, Ishida S, Mizuno N, Mukai T, Ueki Y
Bone
. 2014 Dec;
71:201-9.
PMID: 25445458
Cherubism (OMIM#118400) is a genetic disorder in children characterized by excessive jawbone destruction with proliferation of fibro-osseous lesions containing a large number of osteoclasts. Mutations in the SH3-domain binding protein...
6.
Yoshitaka T, Mukai T, Kittaka M, Alford L, Masrani S, Ishida S, et al.
Cell Rep
. 2014 Sep;
8(6):1752-1766.
PMID: 25220465
Cherubism is caused by mutations in SH3BP2. Studies of cherubism mice showed that tumor necrosis factor α (TNF-α)-dependent autoinflammation is a major cause of the disorder but failed to explain...
7.
Mukai T, Gallant R, Ishida S, Yoshitaka T, Kittaka M, Nishida K, et al.
PLoS One
. 2014 Aug;
9(8):e105518.
PMID: 25144740
Objective: SH3BP2 is a signaling adapter protein which regulates immune and skeletal systems. Gain-of-function mutations in SH3BP2 cause cherubism, characterized by jawbone destruction. This study was aimed to examine the...
8.
Yoshitaka T, Ishida S, Mukai T, Kittaka M, Reichenberger E, Ueki Y
J Bone Miner Res
. 2014 Jul;
29(5):1170-82.
PMID: 24978678
Cherubism is a genetic disorder of the craniofacial skeleton caused by gain-of-function mutations in the signaling adaptor protein, SH3-domain binding protein 2 (SH3BP2). In a knock-in mouse model for cherubism,...
9.
Mukai T, Ishida S, Ishikawa R, Yoshitaka T, Kittaka M, Gallant R, et al.
J Bone Miner Res
. 2014 Jun;
29(12):2618-35.
PMID: 24916406
Cherubism (OMIM# 118400) is a genetic disorder with excessive jawbone resorption caused by mutations in SH3 domain binding protein 2 (SH3BP2), a signaling adaptor protein. Studies on the mouse model...
10.
Yoshitaka T, Kawai A, Miyaki S, Numoto K, Kikuta K, Ozaki T, et al.
J Orthop Res
. 2013 Aug;
31(12):1992-8.
PMID: 23940002
MicroRNAs (miRNAs) are small non-coding RNAs capable of inhibiting gene expression post-transcriptionally and expression profiling can provide therapeutic targets and tools for cancer diagnosis. Chondrosarcoma is a mesenchymal tumor with...